The calcium sensitizer levosimendan reduces the brain natriuretic peptide levels as compared with dobutamine in intensive care unit septic patients with decompensated heart failure

被引:0
|
作者
H Michalopoulou
P Stamatis
A Bakhal
T Kelgiorgis
A Foundouli
A Basile
J Vaitsis
E Reinou
P Batika
D Pragastis
机构
[1] Metaxa Hospital,
来源
Critical Care | / 11卷 / Suppl 2期
关键词
Severe Sepsis; Dobutamine; Brain Natriuretic Peptide; Septic Patient; Left Ventricular Dysfunction;
D O I
10.1186/cc5382
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Effects of levosimendan and dobutamine on levels of N-terminal pro-brain natriuretic peptide in decompensated heart failure
    Gurlek, A.
    Kaya, C. Tulunay
    Turhan, S.
    Erol, C.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2007, 6 : 118 - 118
  • [2] The impact of treatment with levosimendan or dobutamine on brain natriuretic peptide levels in patients with acutely decompensated chronic heart failure. Results from the calcium sensitizer or other inotrope or none in acutely decompensated CHF (CASINO) study
    Zairis, MN
    Apostolatos, C
    Theodosis-Georgilas, A
    Makrygiannis, S
    Batika-Zairi, P
    Billias, D
    Psarogianni, P
    Mainas, K
    Glyptis, M
    Tellis, N
    Beldekos, D
    Foussas, SG
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 324A - 324A
  • [3] The Ca2+-sensitizer levosimendan vesrsus dobutamine on oxidative stress, brain natriuretic peptide and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure
    Avgeropoulou, C
    Andreadou, I
    Demopoulou, M
    Markantoni-Kyoudi, S
    Missovoulos, P
    Androulakis, A
    Kallikazaros, I
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 30 - 30
  • [4] Comparison of levosimendan and dobutamine treatment in reducing N terminal pro-brain natriuretic peptide levels in patients with acutely decompensated heart failure
    Cavusoglu, Y.
    Tek, M.
    Birdane, A.
    Beyaztas, A.
    Demirustu, C.
    Unalir, A.
    Gorenek, B.
    Ata, N.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2007, 6 : 97 - 97
  • [5] The impact of treatment with levosimendan or dobutamine on brain natriuretic peptide levels in patients with acutely decompensated chronic heart failure. Results from the CASINO study
    Zairis, M.
    Apostolatos, C.
    Mytas, D.
    Kouris, N.
    Karidis, K.
    Babalis, D.
    Cokkinos, D. V.
    Foussas, S. G.
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 : 72 - 73
  • [6] Brain natriuretic peptide and inteleukin 6 levels are markedly reduced in patients with advanced chronic heart failure following infusion with the calcium sensitizer levosimendan
    Kyrzopoulos, S
    Chaidaroglou, A
    Adamopoulos, S
    Rassias, J
    Ilodromitis, E
    Degiannis, D
    Koniavitou, K
    Kremastinos, D
    [J]. EUROMEDLAB 2003: PROCEEDINGS OF THE 15TH IFCC-FESCC EUROPEAN CONGRESS OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, : 593 - 599
  • [7] Levosimendan, compared to dobutamine, reduces mortality in patients with a history of heart failure
    Cohen-Solal, A.
    Mebazaa, A.
    Thakkar, R.
    Schulz, G.
    Huang, B.
    Padley, R. J.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2007, 6 : 109 - 109
  • [8] Concentrations of brain natriuretic peptide in the plasma predicts outcomes of treatment of children with decompensated heart failure admitted to the Intensive Care unit
    Tan, Lin-Hua
    Jefferies, John L.
    Liang, Jian-Feng
    Denfield, Susan W.
    Dreyer, William J.
    Mott, Antonio R.
    Grenier, Michelle A.
    Dickerson, Heather A.
    Price, Jack F.
    Towbin, Jeffrey A.
    Ou, Ching-Nan
    Chang, Anthony C.
    [J]. CARDIOLOGY IN THE YOUNG, 2007, 17 (04) : 397 - 406
  • [9] Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with differsent blood BNP levels
    Hai-Yan Pan
    Jian-Hua Zhu
    Yong Gu
    Xiao-Hong Yu
    Min Pan
    Hong-Yin Niu
    [J]. BMC Cardiovascular Disorders, 14
  • [10] Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with differsent blood BNP levels
    Pan, Hai-Yan
    Zhu, Jian-Hua
    Gu, Yong
    Yu, Xiao-Hong
    Pan, Min
    Niu, Hong-Yin
    [J]. BMC CARDIOVASCULAR DISORDERS, 2014, 14